Product Information
MORPHINE SULFATE IR 30 MG TAB is a generic product labeled by SpecGx LLC, priced at $0.3414 per EA under NDC 00406511901. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on Aug 21, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
SpecGx LLCNDC
00406511901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA215194FDA Approved
8/21/2023
TE Code
AB
On Market Since
9/1/2023
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE IR 30 MG TAB has been published 147 times since Dec 13, 2023, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3414 per EA |
|---|---|
| All-time high | $0.4546 (Dec 10, 2025) |
| All-time low | $0.2773 (Nov 20, 2024) |
| 52-week high | $0.4546 |
| 52-week low | $0.3414 |
| Median price | $0.3991 |
| Average price | $0.3889 |
| Largest weekly change | -34.0% (Nov 20, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SpecGx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Morphine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE IR 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE IR 30 MG TAB, manufactured by SpecGx LLC, is $0.3414 per EA (NDC 00406511901), effective Sep 30, 2026.
How has the price of MORPHINE SULFATE IR 30 MG TAB changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE IR 30 MG TAB has declined 10.5%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE IR 30 MG TAB?
Since Dec 13, 2023, the NADAC for MORPHINE SULFATE IR 30 MG TAB has ranged from a low of $0.2773 (Nov 20, 2024) to a high of $0.4546 (Dec 10, 2025), with a median of $0.3991 per EA.
Are there cheaper alternatives to MORPHINE SULFATE IR 30 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MORPHINE SULFATE IR 30 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures MORPHINE SULFATE IR 30 MG TAB?
MORPHINE SULFATE IR 30 MG TAB (NDC 00406511901) is labeled by SpecGx LLC, and CMS classifies it as a generic product.